126 related articles for article (PubMed ID: 37771218)
21. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.
Hu Z; Dong J; Wang LE; Ma H; Liu J; Zhao Y; Tang J; Chen X; Dai J; Wei Q; Zhang C; Shen H
Carcinogenesis; 2012 Apr; 33(4):828-34. PubMed ID: 22298638
[TBL] [Abstract][Full Text] [Related]
22. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
23. miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.
Rinnerthaler G; Hackl H; Gampenrieder SP; Hamacher F; Hufnagl C; Hauser-Kronberger C; Zehentmayr F; Fastner G; Sedlmayer F; Mlineritsch B; Greil R
Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26821018
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA analysis of breast ductal fluid in breast cancer patients.
Do Canto LM; Marian C; Willey S; Sidawy M; Da Cunha PA; Rone JD; Li X; Gusev Y; Haddad BR
Int J Oncol; 2016 May; 48(5):2071-8. PubMed ID: 26984519
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment.
Kaboli PJ; Rahmat A; Ismail P; Ling KH
Pharmacol Res; 2015 Jul; 97():104-21. PubMed ID: 25958353
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype.
Blenkiron C; Goldstein LD; Thorne NP; Spiteri I; Chin SF; Dunning MJ; Barbosa-Morais NL; Teschendorff AE; Green AR; Ellis IO; Tavaré S; Caldas C; Miska EA
Genome Biol; 2007; 8(10):R214. PubMed ID: 17922911
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer and microRNAs: therapeutic impact.
Iorio MV; Casalini P; Piovan C; Braccioli L; Tagliabue E
Breast; 2011 Oct; 20 Suppl 3():S63-70. PubMed ID: 22015296
[TBL] [Abstract][Full Text] [Related]
28. Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
Soon PS; Provan PJ; Kim E; Pathmanathan N; Graham D; Clarke CL; Balleine RL
Clin Exp Metastasis; 2018 Feb; 35(1-2):3-13. PubMed ID: 29214365
[TBL] [Abstract][Full Text] [Related]
29. Correlation of miRNA expression profiling in surgical pathology materials, with Ki-67, HER2, ER and PR in breast cancer patients.
Sakurai M; Masuda M; Miki Y; Hirakawa H; Suzuki T; Sasano H
Int J Biol Markers; 2015 May; 30(2):e190-9. PubMed ID: 25907662
[TBL] [Abstract][Full Text] [Related]
30. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study.
Marino AL; Evangelista AF; Vieira RA; Macedo T; Kerr LM; Abrahão-Machado LF; Longatto-Filho A; Silveira HC; Marques MM
BMC Cancer; 2014 Oct; 14():739. PubMed ID: 25277099
[TBL] [Abstract][Full Text] [Related]
32. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential.
Asiaf A; Ahmad ST; Arjumand W; Zargar MA
Methods Mol Biol; 2018; 1699():23-43. PubMed ID: 29086366
[TBL] [Abstract][Full Text] [Related]
34. miRNA profiling reveals a potential role of milk stasis in breast carcinogenesis.
Gu YQ; Gong G; Xu ZL; Wang LY; Fang ML; Zhou H; Xing H; Wang KR; Sun L
Int J Mol Med; 2014 May; 33(5):1243-9. PubMed ID: 24584717
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
36. miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.
Pessôa-Pereira D; Evangelista AF; Causin RL; da Costa Vieira RA; Abrahão-Machado LF; Santana IVV; da Silva VD; de Souza KCB; de Oliveira-Silva RJ; Fernandes GC; Reis RM; Palmero EI; Marques MMC
BMC Cancer; 2020 Feb; 20(1):143. PubMed ID: 32087690
[TBL] [Abstract][Full Text] [Related]
37. Dynamics of circulating microRNAs as a novel indicator of clinical response to neoadjuvant chemotherapy in breast cancer.
Zhu W; Liu M; Fan Y; Ma F; Xu N; Xu B
Cancer Med; 2018 Sep; 7(9):4420-4433. PubMed ID: 30099860
[TBL] [Abstract][Full Text] [Related]
38. Definition and validation of a custom protocol to detect miRNAs in the spent media after blastocyst culture: searching for biomarkers of implantation.
Cimadomo D; Rienzi L; Giancani A; Alviggi E; Dusi L; Canipari R; Noli L; Ilic D; Khalaf Y; Ubaldi FM; Capalbo A
Hum Reprod; 2019 Sep; 34(9):1746-1761. PubMed ID: 31419301
[TBL] [Abstract][Full Text] [Related]
39. Identification of featured biomarkers in breast cancer with microRNA microarray.
Zhang M; Liu D; Li W; Wu X; Gao C; Li X
Arch Gynecol Obstet; 2016 Nov; 294(5):1047-1053. PubMed ID: 27365106
[TBL] [Abstract][Full Text] [Related]
40. Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f, a microRNA targeting CYP19A1.
Shibahara Y; Miki Y; Onodera Y; Hata S; Chan MS; Yiu CC; Loo TY; Nakamura Y; Akahira J; Ishida T; Abe K; Hirakawa H; Chow LW; Suzuki T; Ouchi N; Sasano H
J Pathol; 2012 Jul; 227(3):357-66. PubMed ID: 22407818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
